PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
The trial that could revolutionise medicine safety
Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.
Balancing the scale: the role of oral anticoagulants in atrial fibrillation
Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.
Chronic pain – the role of pharmacists
Pharmacists play a vital role supporting patients with chronic pain.
Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...
Oxford Uni vaccine ‘highly effective’ against COVID-19
The University of Oxford/AstraZeneca vaccine, which is easier to transport and cheaper to produce than other vaccine candidates, is ‘highly effective’, late stage trials of the vaccine have shown.
What pharmacists need to know about nicotine vaping products
Strict legal requirements to dispense nicotine vaping products for smoking cessation are now in use. Here’s what you need to know.
Meet PSA’s new Vaccination Ambassador
After a nationwide search, Melbourne-based community pharmacist Anna Theophilos MPS has been appointed PSA’s Vaccination Ambassador.
